Follicular dendritic cells inhibit human B-lymphocyte proliferation

A S Freedman1, J M Munro, K Rhynhart

  • 1Department of Medicine, Harvard Medical School, Boston, MA.

Blood
|September 1, 1992
PubMed

Insights

Follicular dendritic cells (FDCs) can inhibit B-cell proliferation. Metabolically active FDCs, but not fixed ones, suppress B-cell growth, suggesting a regulatory role in immune responses.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • B lymphocytes interact with follicular dendritic cells (FDCs) in germinal centers.
  • FDCs are hypothesized to regulate B-cell growth and differentiation via cell-cell interactions.

Purpose of the Study:

  • To investigate the role of FDCs in regulating B-cell proliferation.
  • To determine if FDCs can inhibit B-cell growth and differentiation.

Main Methods:

  • Isolation of highly enriched FDCs using the monoclonal antibody DRC-1.
  • Culture of irradiated FDCs with mitogen-stimulated B cells.
  • Assessment of B-cell proliferation via 3H-TdR uptake.
  • Analysis of the effect of FDC supernatants on B-cell proliferation.

Main Results:

  • Irradiated FDCs inhibited B-cell proliferation by up to 80%.
  • Paraformaldehyde-fixed FDCs did not inhibit B-cell proliferation, indicating the need for metabolic activity.
  • Supernatants from cultured FDCs also demonstrated inhibitory effects on B-cell proliferation.

Conclusions:

  • FDCs possess the ability to downregulate the clonal expansion of B cells.
  • This inhibitory function of FDCs is crucial for normal immune responses within lymphoid follicles.
  • Dysfunctional FDC inhibition may contribute to infectious and neoplastic diseases affecting germinal centers.